U.S. Securities & Exchange Commission
SEC Seal
Home | Search Home | Latest Filings | Previous Page
U.S. Securities and Exchange Commission


ARCH Venture Partners X Overage, L.P. (0001768905)
State location: IL | State of Inc.: DE | Fiscal Year End: 1231
Business Address
8755 W. HIGGINS ROAD, SUITE 1025
CHICAGO IL 60631
773-380-6600
Mailing Address
8755 W. HIGGINS ROAD, SUITE 1025
CHICAGO IL 60631
Ownership Reports for Issuers: (Click on issuer name to see other owners for the issuer, or CIK for issuer filings.)

Issuer Filings Transaction Date Type of Owner
Maze Therapeutics, Inc. 0001842295 2025-01-30 10 percent owner
Boundless Bio, Inc. 0001782303 2024-03-27 10 percent owner
Prime Medicine, Inc. 0001894562 2024-02-15 10 percent owner
Neumora Therapeutics, Inc. 0001885522 2023-09-14 10 percent owner
Erasca, Inc. 0001761918 2021-07-15 10 percent owner
Verve Therapeutics, Inc. 0001840574 2021-06-16 10 percent owner
Sana Biotechnology, Inc. 0001770121 2021-02-03 10 percent owner
Sienna Biopharmaceuticals, Inc. 0001656328 2019-02-22 10 percent owner


Items 1 - 0

The information presented below contains only portions of the information presented in the referenced filing or filings.
You should consult the original filing for complete information. Hyperlinks to the forms are provided for your convenience.

Acquistion or Disposition Transaction Date Deemed Execution Date Issuer Form Transaction Type Direct or Indirect Ownership Number of Securities Transacted Number of Securities Owned Line Number Issuer CIK Security Name

http://www.sec.gov/cgi-bin/own-disp


Modified: 04/22/2016